» Authors » K Yanagisawa

K Yanagisawa

Explore the profile of K Yanagisawa including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 450
Citations 3319
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu Z, Yanagisawa K, Griesing S, Iwai M, Kano K, Hotta N, et al.
Oncogene . 2017 Feb; 36(26):3740-3748. PMID: 28192407
TTF-1, also known as NKX2-1, is a transcription factor that has indispensable roles in both lung development and physiology. We and others have reported that TTF-1 frequently exhibits high expression...
2.
Cassidy S, Stenger B, van Dongen L, Yanagisawa K, Anderson R, Wan V, et al.
Comput Vis Image Underst . 2016 Jul; 148:193-200. PMID: 27375348
Adults with Autism Spectrum Conditions (ASC) experience marked difficulties in recognising the emotions of others and responding appropriately. The clinical characteristics of ASC mean that face to face or group...
3.
Udo M, Muneta T, Tsuji K, Ozeki N, Nakagawa Y, Ohara T, et al.
Osteoarthritis Cartilage . 2016 Feb; 24(7):1284-91. PMID: 26915639
Objective: In a rat monoiodoacetic acid (MIA)-induced arthritis model, the amount of MIA commonly used was too high, resulting in rapid bone destruction. We examined the effect of MIA concentrations...
4.
Knight E, Williams H, Stevens A, Kim S, Kottwitz J, Morant A, et al.
Mol Psychiatry . 2014 Oct; 20(1):109-17. PMID: 25349165
Certain mutant Alzheimer's amyloid-β (Aβ) peptides (that is, Dutch mutant APP(E693Q)) form complexes with gangliosides (GAβ). These mutant Aβ peptides may also undergo accelerated aggregation and accumulation upon exposure to...
5.
Ariizumi H, Saito B, Uto Y, Hattori N, Nakashima H, Yanagisawa K, et al.
Bone Marrow Transplant . 2014 Oct; 50(2):301-3. PMID: 25347005
No abstract available.
6.
Tago K, Funakoshi-Tago M, Itoh H, Furukawa Y, Kikuchi J, Kato T, et al.
Oncogene . 2014 Jan; 34(3):314-22. PMID: 24469041
Tumor suppressor protein p19(ARF) (Arf; p14(ARF) in humans) functions in both p53-dependent and -independent modes to counteract hyper-proliferative signals caused by proto-oncogene activation, but its p53-independent activities remain poorly understood....
7.
Sakatani K, Takemoto N, Tsujii T, Yanagisawa K, Tsunashima H
Adv Exp Med Biol . 2013 Jul; 789:449-454. PMID: 23852528
The aim of this study was to develop a NIRS-based neurofeedback system to modulate activity in the prefrontal cortex (PFC). We evaluated the effectiveness of the system in terms of...
8.
Yanagisawa K, Yue S, van der Vliet H, Wang R, Alatrakchi N, Golden-Mason L, et al.
J Viral Hepat . 2013 Jul; 20(8):556-65. PMID: 23808994
Hepatic CD1d-restricted and natural killer T-cell populations are heterogeneous. Classical 'type 1' α-galactosylceramide-reactive CD1d-restricted T cells express 'invariant' TCRα ('iNKT'). iNKT dominating rodent liver are implicated in inflammation, including in...
9.
Fan Q, Iosbe I, Asou H, Yanagisawa K, Michikawa M
J Am Aging Assoc . 2013 Apr; 24(1):1-10. PMID: 23604870
The importance of apolipoprotein E (apoE) in the central nervous system (CNS) became increasingly clear since the descovery that apoE ε4 allele is a major risk factor for Alzheimer's disease....
10.
Yanagisawa K, BOSWORTH D
Q Bull Sea View Hosp . 2010 Mar; 9(1):21-4. PMID: 20261526
No abstract available.